Drawing for HUNTER-FLEMING

USPTO serial 86520961

HUNTER-FLEMING

Reviewed by CopyMark Law Group

Reg. 4876938Status 710
Filing date
Status date
Registration date
Dec 29, 2015
Examiner
MIDDLETON, BERNICE L
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with HUNTER-FLEMING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony P. Venturino

ANTHONY P. VENTURINO Vorys, Sater, Seymour And Pease LLPPO BOX 2255Columbus, OH 43216-2255UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical, medicinal, biological and chemical preparations for the treatment of cancers, auto immune diseases, peripheral neuropathies, pain, chronic neurodegenerative diseases, peripheral neuropathies, acute neurological degenerative conditions, peripheral arterial diseases, coronary artery diseases, myocardial infarction, cerebrovascular diseases, liver and kidney ischaemia, diabetes, vascular diseases of the kidney, obesity, inflammatory airways diseases, inflammatory bowel disease, Chrone's disease, inflammatory diseases characterized by degeneration of articular cartilage, wound healing, toxicity and peripheral neuropathies caused by chemotherapeutic agents, inflammatory skin conditions, motor neuron disease, metabolic syndrome X, acromegaly, bone diseases; veterinary preparations for the treatment of neurodegenerative and inflammatory diseases in domestic animals and livestock; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing for medical, pharmaceutical and veterinary purposesSECTION 8 - CANCELLED—
042Scientific and technological services, namely, medical and scientific research services in the field of neurodegenerative and inflammatory disorders; research and development of medical, pharmaceutical and veterinary products; medical, pharmaceutical and veterinary product development; clinical product development of chemical and biological products for pharmaceutical, medical and veterinary purposes; medical and scientific research, namely, clinical trials; new drug design and developmentSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 15, 2022C8..CANCELLED SEC. 8 (6-YR)—
Dec 29, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 21, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 29, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 28, 2015DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Sep 28, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 14, 2015IUCNNOTICE OF ALLOWANCE CANCELLED—
Sep 14, 2015D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Aug 18, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 23, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 23, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 7, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 7, 2015DOCKASSIGNED TO EXAMINER—
Feb 11, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 5, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance